These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30223656)

  • 1. [Therapy for peptic ulcer disease].
    Lukáš M
    Vnitr Lek; 2018; 64(6):595-599. PubMed ID: 30223656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs].
    Cozzarini W; Rath J; Bauer A; Györög I; Györög M; Prenner M; Trianto T; Maderbacher H; Höller E; Grusch B; Sebesta C
    Wien Med Wochenschr; 2003; 153(13-14):295-303. PubMed ID: 12924104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peptic ulcer: facts and questions -- 2010].
    Hagymási K; Tulassay Z
    Orv Hetil; 2010 Jun; 151(26):1054-61. PubMed ID: 20558352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines of treatment for non-bleeding peptic ulcer disease].
    Cheung DY; Jung HY; Song HJ; Jung SW; Jung HC; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):285-97. PubMed ID: 19934610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
    Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
    Tytgat GN
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M; Bianchi Porro G
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of acid secretion in peptic ulcer disease.
    Feldman M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.